Narya Capital

Narya Capital is an early-stage venture capital firm located in Cincinnati, Ohio. Focused on a thesis-driven investment approach, Narya Capital aims to provide long-term capital to individuals and teams that leverage technology to address significant challenges. The firm is backed by a diverse group of limited partners, including accomplished investors, entrepreneurs, and institutions. Narya Capital Fund I, launched in 2020, specifically invests in companies across the United States, fostering innovation and supporting the growth of emerging technologies.

Colin Greenspon

Co-Founder

13 past transactions

Branch

Series C in 2022
Branch Financial, Inc. is an insurance agency based in Columbus, Ohio, founded in 2017 by Steve Lekas and Joe Emison. The company specializes in home and auto insurance, offering a range of products including renters and umbrella insurance, which can be added to auto policies. Utilizing advanced technology, Branch streamlines the process of bundling home and auto insurance online, aiming to enhance accessibility and affordability for its customers. By leveraging community resources, Branch seeks to transform the insurance landscape, making it easier for individuals to obtain necessary coverage.

Kriya Therapeutics

Series C in 2022
Kriya Therapeutics, Inc. is a gene therapy company based in Palo Alto, California, with an additional office in Durham, North Carolina. Founded in 2019, the company specializes in designing and developing innovative treatments for chronic diseases that are both prevalent and severe. Kriya Therapeutics focuses on conditions with well-understood underlying biology, aiming to create one-time gene therapies that provide durable expression of therapeutic proteins in targeted human tissues. The company's team comprises experts and former leaders from prominent gene therapy firms and academic institutions. Utilizing algorithmic tools, scalable infrastructure, and proprietary technology, Kriya Therapeutics seeks to enhance the efficacy and longevity of its therapies, striving to redefine treatment approaches for serious health conditions.

Strive Asset Management

Seed Round in 2022
Strive is an asset management firm whose mission is to restore the voices of everyday citizens in the American economy by leading companies to focus on excellence over politics.

Chapter

Series B in 2022
Chapter is a New York-based company that specializes in providing Medicare advisory services to seniors. It offers personalized consultations to help retirees navigate their healthcare options, including guidance on medical services and recommended medical card programs. Chapter enhances the decision-making process for older adults by offering tailored coupons, deals, tax advice, and relevant news and technology tips. The company's goal is to empower seniors to make informed choices about their health coverage, enabling them to live with purpose and security as they age.

AcreTrader

Series B in 2022
AcreTrader is an agricultural real estate investing platform that helps buyers to buy shares of farmland through an online platform. AcreTrader provides transparency, flexibility, and ease of use to people wanting to invest in farmland while handling all aspects of administration and property management, from insurance and accounting to working with local farmers and improving soil sustainability. The company was founded in 2018 and headquartered in Fayetteville, Arkansas.

Hallow

Series B in 2021
Hallow is a digital platform that aims to energize faith lives and enable conversations with God through guided prayer.

Chapter

Series A in 2021
Chapter is a New York-based company that specializes in providing Medicare advisory services to seniors. It offers personalized consultations to help retirees navigate their healthcare options, including guidance on medical services and recommended medical card programs. Chapter enhances the decision-making process for older adults by offering tailored coupons, deals, tax advice, and relevant news and technology tips. The company's goal is to empower seniors to make informed choices about their health coverage, enabling them to live with purpose and security as they age.

Kriya Therapeutics

Series B in 2021
Kriya Therapeutics, Inc. is a gene therapy company based in Palo Alto, California, with an additional office in Durham, North Carolina. Founded in 2019, the company specializes in designing and developing innovative treatments for chronic diseases that are both prevalent and severe. Kriya Therapeutics focuses on conditions with well-understood underlying biology, aiming to create one-time gene therapies that provide durable expression of therapeutic proteins in targeted human tissues. The company's team comprises experts and former leaders from prominent gene therapy firms and academic institutions. Utilizing algorithmic tools, scalable infrastructure, and proprietary technology, Kriya Therapeutics seeks to enhance the efficacy and longevity of its therapies, striving to redefine treatment approaches for serious health conditions.

AmplifyBio

Funding Round in 2021
AmplifyBio is a biotechnology company that develops next-generation cell and gene therapies. The company's mission is to create pathways for novel treatment advances, cutting-edge technologies, and new research frontiers to advance medical breakthroughs, treatments, and cures for disease. AmplifyBio was founded in 2021 and is headquartered in West Jefferson, OH.

Rumble

Venture Round in 2021
Rumble Inc. operates a video management platform that allows users to watch, share, and upload videos. Founded in 2013 and based in Toronto, Canada, Rumble provides a free-to-use service where users can engage with content by liking, commenting, and subscribing to channels. The platform also features video-on-demand and live streaming capabilities. A key element of Rumble's offering is its rights management technology, utilizing a machine learning algorithm called Rumble Rank, which enhances video verification, clearance, discovery, and licensing for user-generated content. In a short span, Rumble has established itself as a significant player in the online video space, ranking among the top 50 video destinations according to ComScore, with a substantial portion of its revenue generated from the United States.

AcreTrader

Series A in 2021
AcreTrader is an agricultural real estate investing platform that helps buyers to buy shares of farmland through an online platform. AcreTrader provides transparency, flexibility, and ease of use to people wanting to invest in farmland while handling all aspects of administration and property management, from insurance and accounting to working with local farmers and improving soil sustainability. The company was founded in 2018 and headquartered in Fayetteville, Arkansas.

AppHarvest

Series C in 2020
AppHarvest, Inc. is an agricultural technology company that focuses on constructing and operating controlled-environment greenhouse farms. Established in 2017 and headquartered in Morehead, Kentucky, the company aims to produce non-GMO, chemical-free vegetables by integrating traditional farming methods with modern technology. Its greenhouses are designed to optimize water distribution and reduce overall water usage, contributing to more sustainable agricultural practices. Through these innovative approaches, AppHarvest seeks to enhance food production while minimizing environmental impact.

Kriya Therapeutics

Series A in 2020
Kriya Therapeutics, Inc. is a gene therapy company based in Palo Alto, California, with an additional office in Durham, North Carolina. Founded in 2019, the company specializes in designing and developing innovative treatments for chronic diseases that are both prevalent and severe. Kriya Therapeutics focuses on conditions with well-understood underlying biology, aiming to create one-time gene therapies that provide durable expression of therapeutic proteins in targeted human tissues. The company's team comprises experts and former leaders from prominent gene therapy firms and academic institutions. Utilizing algorithmic tools, scalable infrastructure, and proprietary technology, Kriya Therapeutics seeks to enhance the efficacy and longevity of its therapies, striving to redefine treatment approaches for serious health conditions.